As the pace of product development accelerates, the approach to dissolution-method development must advance beyond a manual
method and an assay. A natural progression of the method-development process must include the transfer of the manual method
onto automated instrumentation.
Validating the automated method is the primary challenge when transferring from the manual method. A dissolution scientist
must understand the potential effects from filtration, system interference, carry-over, cleaning parameters, and media replacement.
Automated dissolution instrumentation can help generate good manufacturing practice (GMP) data only when validated testing
parameters can negate these influences, so the dissolution scientist can be confident that results do not differ between the
manual and the automated methods. In addition, all laboratory equipment used to support or generate GMP data about automated
instrumentation must follow an instrument "chain of compliance." Proper documentation must exist that proves each piece of
equipment has been properly qualified and calibrated for its intended use.
Product development life cycle
The level of automated dissolution-method validation depends upon a product's phase of development. For early-phase products,
minimal validation is required to screen the initial batches. Typically, filtration parameters must be established first to
ensure that no amount of active pharmaceutical ingredient (API) is lost with filtration. The initial filtration parameters
could be established manually and then transferred to the automated instrument. Next, automated dissolution-profile testing
is completed to screen several different dissolution media. Profile sampling could be performed at 10, 20, 30, 45, and 60
min and the results compared. Selecting the various dissolution media that are used in the evaluation depends upon the solubility
and stability of the API in each media. This process allows a dissolution chemist to determine quickly the media having the
potential to provide the most discriminating dissolution performance for the product. Once these initial parameters have been
established, a dissolution chemist can use the automated instrumentation to quickly screen early formulations and help formulators
direct their future formulation efforts.
Tips for validating automated dissolution parameters
As the life cycle of the product progresses, automated dissolution-method parameters must be validated if the generated data
have the potential to be included in any type of GMP submission. At this phase of development, a dissolution chemist should
have substantial experience performing both manual and automated dissolutions on a product. This experience can be useful
to select automated dissolution method parameters, which should be able to generate results equivalent to those of manual
Because the manual test is considered the "official" dissolution test, side-by-side dissolution-profile testing should be
conducted manually and with automation. Results could be compared at 10, 20, 30, 45, 60, and infinity minutes. At the infinity
time point, a final sample is taken after the dissolution has progressed with a stirring apparatus speed of 250 rpm for an
additional 30 min after the Q time point. The chosen acceptance criteria for the comparison between the two methods should reflect and compensate for both
nonvariable and highly variable drug products. The results generated at the earlier time points are the most significant because
they have the highest potential for variation between the manual and automated methods. If comparable results are obtained
between the two methods at the earlier time points, a dissolution chemist is more likely to be assured that accurate data
are obtained at all time points of the automated dissolution-profile testing. At later time points, the percent drug released
typically approaches 100%; therefore, not as much variation between the two tests would be expected at these later time points.
Acceptance criteria must be established for results generated at the earlier time points (<85% dissolved) and the later time
points (>85% dissolved) with tighter acceptance criteria established at the later time points.
Ensuring instrument qualification